Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Open Access
- 23 February 2023
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 315 (6) , 1735-1745
Abstract
Dose reduction of biologics for psoriasis could contribute to more efficient use of these expensive medicines. Evidence on opinions of patients with psoriasis regarding dose reduction is sparse. The objective of this study was therefore to explore patients’ perspectives towards dose reduction of biologics for psoriasis. A qualitative study was conducted, comprising semi-structured interviews with 15 patients with psoriasis with different characteristics and treatment experiences. Interviews were analyzed by inductive thematic analysis. Perceived benefits of biologic dose reduction according to patients were minimizing medication use, lowering risks of adverse effects and lowering societal healthcare costs. Patients reported to have experienced a large impact of their psoriasis, and expressed concerns about loss of disease control due to dose reduction. Fast access to flare treatment and adequate monitoring of disease activity were among reported preconditions. According to patients, they should have confidence in dose reduction effects and should be willing to change their effective treatment. Moreover, addressing information needs and involvement in decision-making were deemed important among patients. In conclusion, addressing patients’ concerns, fulfilling information needs, providing the possibility of resuming standard dose, and involving patients in decision-making are important according to patients with psoriasis when considering biologic dose reduction.Keywords
Funding Information
- ZonMw
This publication has 25 references indexed in Scilit:
- Dose reduction of biologic therapy in inflammatory arthritis: A qualitative study of patients' perceptions and needsMusculoskeletal Care, 2018
- The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods studyRheumatology, 2018
- Standards for Reporting Qualitative ResearchAcademic Medicine, 2014
- ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetworkBritish Journal of Dermatology, 2014
- Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients’ opinionClinical Rheumatology, 2014
- A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practiceImplementation Science, 2013
- Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life courseBritish Journal of Dermatology, 2011
- Psoriasis: is the impairment to a patient’s life cumulative?Journal of the European Academy of Dermatology and Venereology, 2010
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Improving the Quality of Health Care in the United Kingdom and the United States: A Framework for ChangeThe Milbank Quarterly, 2001